lipid replacement therapy (Cerenis Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namelipid replacement therapy (Cerenis Therapeutics)
Drug Alias Namelipid replacement therapy (Lypro)
ClassificationSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBarth Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLypro Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLypro Biosciences IncAbionyx Pharma SA
Active IndicationsN/A
Inactive IndicationsBarth Syndrome

Other Information

ATC CodeN/A
Related LinksN/A